Professional Documents
Culture Documents
Shefaly Shorey, Cornelia Chee Yin Ing, Esperanza Debby Ng, Chan Yiong Huak,
Wilson Tam Wai San, Chong Yap Seng
PII: S0022-3956(18)30492-8
DOI: 10.1016/j.jpsychires.2018.08.001
Reference: PIAT 3425
Please cite this article as: Shorey S, Yin Ing CC, Debby Ng E, Yiong Huak C, Wai San WT, Seng CY,
Prevalence and incidence of postpartum depression among healthy mothers: A systematic review and
meta-analysis, Journal of Psychiatric Research (2018), doi: 10.1016/j.jpsychires.2018.08.001.
This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to
our customers we are providing this early version of the manuscript. The manuscript will undergo
copyediting, typesetting, and review of the resulting proof before it is published in its final form. Please
note that during the production process errors may be discovered which could affect the content, and all
legal disclaimers that apply to the journal pertain.
ACCEPTED MANUSCRIPT
TITLE: Prevalence and incidence of postpartum depression among healthy mothers: A
AUTHORS:
Shefaly SHOREYa, Cornelia CHEE Yin Ingb, Esperanza Debby NGa, CHAN Yiong Huakc,
PT
a
Alice Lee Centre for Nursing Studies, Yong Loo Lin School of Medicine, National
RI
University of Singapore; Level 2, Clinical Research Centre, Block MD11, 10 Medical Drive,
Singapore 117597
SC
b
Department of Psychological Medicine, 5 Lower Kent Ridge Road, National University
Hospital, Singapore 119074
U
c
Biostatistics Unit, Yong Loo Lin School of Medicine, Block MD 1, 12 Science Drive 2,
AN
National University of Singapore, Singapore 117549
d
Women’s Centre, 5 Lower Kent Ridge Road, National University Hospital, Singapore
M
119074
CORRESPONDING AUTHOR:
D
Assistant Professor
EP
Email: nurssh@nus.edu.sg
1
ACCEPTED MANUSCRIPT
Abstract
This review aims to examine the prevalence and incidence of postpartum depression among
healthy mothers without prior history of depression including postpartum depression and who
EMBASE, PsycINFO, and PubMed was performed for English articles from the inception of
PT
the database to November 2017, as well as a manual search of the reference lists of the
RI
included articles, and an expert panel was consulted. Across 15,895 articles, 58 articles
(N=37,294 women) were included in the review. The incidence of postpartum depression was
SC
12% [95% CI 0.04 - 0.20] while the overall prevalence of depression was 17% [95% CI 0.15
- 0.20] among healthy mothers without a prior history of depression. Prevalence was similar
U
regardless of the type of diagnostic tool used; however, there were statistical differences in
AN
the prevalence between different geographical regions, with the Middle-East having the
M
highest prevalence (26%, 95% CI 0.13 - 0.39) and Europe having the lowest (8%, 95% CI
0.05 - 0.11). There was no statistical difference in prevalence between different screening
D
time points, but an increasing prevalence was observed beyond six months postpartum.
TE
Intervention studies often neglect healthy mothers. This review reports a similar prevalence
rate of postpartum depression among mothers without history of depression when compared
EP
to mothers with history of depression. Thus, future studies should place equal emphasis on
C
this neglected group of mothers so that targeted interventions and follow-ups can be
AC
The postpartum period is a challenging transition period for mothers, leaving them
depressive episodes can be twice as high as during other periods of a woman’s life (Cox et
al., 1993), and they often go undetected and untreated (Pearlstein et al., 2009), which can
PT
adversely affect the wellbeing of mothers, new born infants (Soe et al., 2016), and other
RI
family members (Letourneau et al., 2012). Mothers suffering from postpartum depression
often display hostility and negligence, have lower tolerance, and are less responsive to their
SC
infants’ needs (Murray et al., 1996; Stein et al., 2014). This not only disrupts mother-infant
bonding and reduces breastfeeding (Pope and Mazmanian, 2016) but also impairs the
U
cognitive, behavioural, and social-emotional development and physical health of the child
AN
(Letourneau et al., 2012; Stein et al., 2014). Moreover, maternal postpartum depression
M
(PPD) was found to be the strongest risk factor for paternal depression, affecting 24 to 50%
of all fathers (Goodman, Janice H., 2004). This leads to increased marital conflicts associated
D
with communication breakdown, feelings of isolation and frustration, and limited interaction
TE
with the child (Davey et al., 2006). Therefore, the early diagnosis, management, and possible
PPD refers to non-psychotic depressive episodes during the postpartum period that
AC
persist for more than two weeks, which has an estimated prevalence of 13% (O’Hara and
Swain, 1996). In the Diagnostic and Statistical Manual of Mental Disorders, 5th Edition
(DSM-5, American Psychological Association, 2013), PPD shares the same diagnostic
criteria as major depressive disorder, with an additional postpartum onset specifier of four
transient mood lability, insomnia, disorganised behaviour, irritability, and agitation (Monzon
3
ACCEPTED MANUSCRIPT
et al., 2014). While studies have suggested a multifactorial aetiology of PPD, such as
psychosocial stressors (Beck, 2001; O’Hara and Swain, 1996) and biological factors
(Brummelte and Galea, 2016), the specific aetiology of PPD still remains unclear.
Many studies have shown substantial interest in the prevalence of PPD and their
predictors, with most reporting the significance of history of psychiatric illnesses on the
PT
prevalence of PPD (O’Hara et al., 1991; Patel et al., 2012). In addition, women with a history
RI
of PPD have an increased risk of experiencing a recurrence in subsequent deliveries (Banti et
al., 2011; Cox et al., 1993; Rasmussen et al., 2017). Results from Rasmussen’s (2017) study
SC
reported a 15 to 21% recurrence risk of affective disorders in women who had no prior
psychiatric disorders but were diagnosed with PPD after their first childbirth. This recurrence
U
risk is 27 to 46 times higher in women with history of PPD after first birth. Since having a
AN
history of depression is a high risk factor of PPD, many studies included and focused on the
M
without a prior history of depression (including PPD). In previous studies (Banti et al., 2011;
D
Chee et al., 2005), women without a history of depression are shown to be as likely to have
TE
subsequent depressive episodes during the perinatal period as those with prior history. This
rate of depression was 7.7% in the postpartum period. As mothers without prior history of
EP
depression are at a similar risk of PPD, the effects of PPD are equally detrimental to them and
C
their family; hence, knowing the prevalence of first onset of PPD among healthy mothers is
AC
vital in preventing further elevations of symptoms and reducing the recurrence risk.
(Andrews-Fike, 1999; Leahy-Warren and McCarthy, 2007; Patel et al., 2012) or focused on
specific countries (Jones and Coast, 2013; Ozcan et al., 2017; Upadhyay et al., 2017); hence,
a global prevalence of PPD and their moderating factors were hardly reported in those
4
ACCEPTED MANUSCRIPT
postpartum reviews. The most recent review by Hahn-Holbrook and colleagues (2018)
reported a pooled global prevalence of 17.7% for PPD from 291 studies, and identified
significant risk factors like maternal mortality, infant mortality, long working hours of
women at the childbearing age, and nations with high income inequality. However, the
review was limited in its inclusivity of using only the Edinburgh Postnatal Depression Scale
PT
(EPDS), and study samples of mothers who were less than one year postpartum were
RI
included. As self-reported measures tend to report higher PPD prevalence than clinical
interviews (O’Hara and Swain, 1996), this may have resulted in an overestimation of global
SC
prevalence. A postpartum review by Leahy-Warren (2007) reported a wide range of
prevalence estimates (4.4-73.7%) in the postpartum period and attributed it to the difference
U
in sampling methods, measurement instruments, and sociodemographic variances across the
AN
studies. However, no meta-analysis and meta-regression have been conducted thus far to
M
account for the heterogeneity of the studies statistically, and the moderators of heterogeneity
population groups (i.e. immigrants, ethnic minorities, mothers living in rural areas, first time
mothers)(Falah-Hassani et al., 2015; Jones and Coast, 2013; Ozcan et al., 2017; Upadhyay et
EP
al., 2017; Vigod et al., 2010; Villegas et al., 2011). To the best of our knowledge, no review
C
has been done among mothers without prior psychiatric history and who had given birth to
AC
healthy infants during the postpartum period. As this period is a stressful transition period for
new mothers, it is important to see the development of depression among healthy mothers.
This group has been often neglected, and it has been shown that mothers with PPD influence
the future development of their healthy newborns (Ali et al., 2013; Letourneau et al., 2012;
Soe et al., 2016). Hence, this review aims to provide new insights on the prevalence and
incidence of PPD among healthy mothers, without prior history of mental illnesses, including
5
ACCEPTED MANUSCRIPT
PPD, with healthy infants during the stressful postpartum period so that appropriate
interventions can be planned for this specific group of mothers, which may benefit not only
METHODS
Search Strategy
PT
The meta-analysis was conducted in accordance with Preferred Reporting Items for
RI
Systematic Review and Meta-Analyses (PRISMA) guidelines (Liberati et al., 2009)
(Appendix 1). A three-step strategy was used to identify relevant studies: (i) a systematic
SC
search of electronic databases, (ii) a manual search of the reference lists of the included
articles, and (iii) consultation with an expert panel. The electronic databases searched were
U
ClinicalTrials.gov, CINAHL, EMBASE, PsycINFO, and PubMed. Grey literature was
AN
searched from MedNar. Only papers published in English were searched for from the
M
inception of the databases to November 2017. The review was registered in PROSPERO
(CRD 42018081484). The key MeSH search terms used were: (“mothers” or “females” or
D
restriction on study types during the preliminary search. Studies validating different versions
EP
of depression assessment tools while reporting the prevalence and/or incidence of PPD were
C
included; however, studies on PPD treatment efficacy and clinical trials involving PPD
AC
interventions were excluded. Elaboration on search strategy and search keywords used for
A list of inclusion and exclusion criteria was generated prior to identifying relevant
studies. Studies were only included if they had: (i) assessed a group of healthy mothers
without prior history of clinical or self-reported depression post-birth, (ii) analyzed the
6
ACCEPTED MANUSCRIPT
overall prevalence or incidence of depression, (iii) determined the prevalence or incidence of
clinically structured interviews, and (iv) provided sufficient information for the authors to
calculate the aggregated prevalence of depression in the selected group of mothers. To get an
overall view, studies on perinatal depression were also included, but only data on postnatal
PT
follow-ups were extracted.
RI
Studies were excluded if: (i) the study sample consisted solely of adolescent mothers
below 18 years old, (ii) the study sample consisted of mothers who delivered preterm,
SC
stillborn, or babies with congenital anomalies, (iii) the study sample consisted of mothers
who had a history or existing psychiatric illness and major medical conditions such as
U
cardiovascular and cancer, (iv) the outcome interests were indistinguishable from women
AN
with maternity blues, bipolar disorder, or primary psychotic disorders, and/or (v) the study
M
did not use a validated diagnostic tool. If the study sample was a subset of a previous study,
the sample demographics of the earlier study were screened for eligibility instead.
D
Study Selection
TE
Two reviewers with expertise in PPD independently reviewed the shortlisted articles
against the inclusion criteria. In case of any discrepancies, a third reviewer was consulted. A
EP
PRISMA flowchart summarizing the search process and exclusion of the studies is presented
C
in Figure 1. After the removal of duplicates, the search procedure yielded 12,387 articles. The
AC
abstracts and titles of these articles were reviewed for potential relevance; only 325 articles
were shortlisted for the screening of full-text and language. Two hundred and fourteen
articles were further reviewed for inclusion, and 58 studies were finalized.
Based on the PRISMA checklist (Moher, 2009), data were extracted and presented in
a table (Appendix 4). From each included study, features such as: (i) publication details
(primary author’s last name and year of publication), (ii) geographical region and country,
7
ACCEPTED MANUSCRIPT
(iii) number of participants, (iv) mean age/age range of the participants, (v) timepoints of
PPD screening, and (vi) description of the instruments used to assess depressive symptoms,
including cut-offs and diagnostic criteria, were extracted. In order to have a comprehensive
view, postpartum data were also extracted from 13 perinatal studies. Studies that reported
PT
For the analysis, standard error (SE) values were extracted from the studies, since
RI
they are more commonly reported than the 95% confidence interval (CI). When both SE and
95% CI were not provided, SE was calculated using the formula (SE = √P × (1 − P)/N),
SC
where P is the proportion of the cases reported and N is the denominator of the prevalence
Statistical Analysis
U
AN
Depression was reported as a dichotomous variable (presence versus absence) in all
M
studies. If studies used both a self-reported assessment and a clinical interview as the
diagnostic instrument to determine PPD, prevalence estimates derived from the clinical
D
interviews were used in the analysis. For studies that reported prevalence of both minor
TE
depression and major depression, unless an overall prevalence estimate was provided, only
estimates for major depression were included in the analysis in order to adhere to DSM-5’s
EP
diagnostic criteria for PPD. For longitudinal studies, only the prevalence rate from the latest
C
PPD screening was included in the analysis as our study would like to investigate the long-
AC
Review Manager Version 5.3 was used to conduct the meta-analysis. The studies
included in the meta-analysis have been presented in Appendix 5. Prevalence rate was used
instead of log odds ratio as it was readily provided in all the studies. Quantitative
heterogeneity was explored using Cochran’s Q-test (Chi2) and I2 statistics. The I2 statistic
attributes the total percentage of variance among studies to heterogeneity rather than
8
ACCEPTED MANUSCRIPT
sampling chance (Higgins et al., 2003). The estimates of heterogeneity (I2) were considered
low at 25%, moderate at 50%, and high at 75% (Higgins et al., 2003). Cochran’s Q tests the
null hypothesis which claims that the prevalence estimates come from the same distribution;
a p-value of < 0.05 indicates that they are heterogeneous and do not come from the same
distribution. The random effects model was used to derive the overall prevalence estimate
PT
when heterogeneity was moderate or high (I2>50%). The random effects model was preferred
RI
over the fixed effects model because it took into consideration the variance in effect sizes
between studies and led to a greatly conservative null hypothesis (Han and Eskin, 2011). The
SC
results of the meta-analysis were represented in a forest plot, visually displaying the effect
size and 95% CI for each study. The combined estimates, 95% CI, Z-value, and heterogeneity
U
test values (i.e. T2, Chi2, I2) were reported for each analysis.
AN
Stata 11.0 was used to perform random effects meta-regression to investigate the
M
impact of moderator variables on study effect size when significant heterogeneity was
detected. Based on previous reviews (Leahy-Warren and McCarthy, 2007; O’Hara and
D
Swain, 1996; Patel et al., 2012) and the clinical expertise of the authors, three study
TE
characteristics were assessed as potential moderators: (i) mean age of the mothers, (ii) parity,
Subgroup analyses were performed to investigate the effect of time of assessment and
C
the method of assessment on the prevalence of PPD. Studies with assessment time points in a
AC
similar period were grouped together as such: (i) 0-3 months, (ii) 4-6 months, (iii) 7-12
months, and (iv) more than 12 months. Methods of assessment were stratified as: (i) clinical
interviews, and (ii) self-reported assessments. Subgroup analyses were also used to examine
the effect of geographic region by grouping studies based on the United Nations’ standard
geographic region classification (United Nations, 2013): (i) Asia, (ii) Africa, (iii) Australia,
(iv) Europe, (v) Middle Eastern, (vi) North America, and (vii) South America. Middle
9
ACCEPTED MANUSCRIPT
Eastern countries were differentiated from Asian countries based on differences in traditions
Quality of Assessment
The quality of the included studies was appraised by two reviewers using Downs and
Black’s instrument for observational studies (Downs and Black, 1998). It assesses the clarity
PT
and completeness of the articles and rates the external and internal validity of the study
RI
design. In order to adopt a holistic approach, all studies were included for meta-analyses
regardless of their quality scores. Detailed scoring of each included study can be found in
SC
Appendix 6.
RESULTS
U
Thirty prospective cohort studies, 26 cross sectional studies, and two case-control
AN
studies covering a total of 37,294 women in the postpartum period were included in the
M
analysis. This review included 17 studies that adopted clinical interviews to diagnose PPD
and 39 studies that used varied validated self-report measurement tools to determine the
D
presence of PPD. When stratified according to time points of assessment for depression, 25
TE
studies reported prevalence in the first three months postpartum, 18 studies between the
fourth to sixth month, seven studies between the seventh to twelfth month, and only six
EP
studies reported beyond one year postpartum. When stratified according to region, 13 studies
C
reported prevalence in Asia, six in Europe, nine in the Middle East, 13 in North America, five
AC
in South America, seven in Australia, and three in Africa. Only six out of 58 studies reported
the incidence of PPD. Varied instruments were used to measure PPD. The majority of the
studies (n = 27) used the EPDS with 16 studies using a cut-off score of 13. Other scales used
were the Beck’s Depression Inventory (BDI; n = 4), Center for Epidemiological Studies
Diagnose Depression (IDD; n = 1), Hamilton Depression Scale (HAM-D; n = 1), and
10
ACCEPTED MANUSCRIPT
Depression Anxiety Stress Scales (DASS; n = 1). Table 1 summarizes the major
characteristics of the included studies, which were sorted by alphabetical order of the authors’
name.
The global prevalence of PPD among mothers was 17% (95% CI 0.15 - 0.20; Z =
15.3, df = 55, T2 = 0.01, I2 = 98%) based on the random effects model. Figure 2 demonstrates
PT
the results of 56 studies that reported the prevalence of depression among healthy postpartum
RI
mothers.
SC
regression against mean age (p = 0.983), proportion of primiparous mothers (p = 0.099), and
proportion of single mothers was conducted, but none of the moderators were found to have a
U
statistically significant effect (Table 2). Twenty-nine studies were excluded from the meta-
AN
regression due to insufficient data, leaving only 27 eligible studies for the meta-regression
analysis. The tau (T2) value of 0.673 suggests that there is little heterogeneity between the 27
M
studies.
D
six months postpartum; however, there was no statistical difference between groups (p =
0.29). Prevalence was highest at 25% (95% CI 0.12 - 0.39) after one year postpartum, closely
EP
postpartum (16%, 95% CI 0.13 - 0.19), then 0 to 3months (14%, 95% CI 0.11 - 0.17). The
AC
geographical regions, with the Middle East having the highest prevalence of 26% (95% CI
0.13 - 0.39), followed by Australia (21%, 95% CI 0.16 - 0.25), South America (19%, 95% CI
0.18 - 0.21), Asia (16%, 95% CI 0.13 - 0.20), North America (16%, 95% CI 0.11 - 0.20),
11
ACCEPTED MANUSCRIPT
Africa (11%, 95% CI 0.05 - 0.17), then Europe (8%, 95% CI 0.05 - 0.11). The results can be
= 0.30), with slightly higher prevalence in self-reported assessment tools (19%, 95% CI 0.17
- 0.22) than clinical interviews (17%, 95% CI 0.05 - 0.11) (Figure 5).
PT
The incidence of PPD was 12% (95% CI 0.04 - 0.20; Z = 3.05, df = 5, tau2 = 0.01, I2
RI
= 97%) based on the random effects model. A forest plot of the six studies that reported the
incidence of PPD is shown in Figure 6. Meta-regression was not conducted due to the small
SC
number of studies.
A funnel plot (Figure 7) was generated using RevMan 5.3 to test for publication bias.
U
According to the visual representation of the funnel plot, the slight asymmetry indicates
AN
possible publication bias.
M
DISCUSSION
Results from the meta-analysis of 58 studies suggest that the overall prevalence of
D
PPD is 17% (95% CI 0.15 - 0.20). This estimate falls within previously published estimates
TE
of 13% to 19.2% (Gavin et al., 2005; O’Hara and Swain, 1996) and is similar to Hanhn-
Holbrook’s (2018) finding of 17.7%. However, it is higher than the prevalence of 0.6%
EP
primiparous mothers without prior psychiatric history. Unique to this review, the prevalence
AC
regions, in contrast to previous reviews (Fisher et al., 2012; Gavin et al., 2005; Woody et al.,
2017) in which prevalence was generated based on the World Bank’s guidelines of income
level (Fisher et al., 2012; Woody et al., 2017), or as individual countries (Gavin et al., 2005).
Also, previous reviews did not investigate the effect of the time of assessment on the
12
ACCEPTED MANUSCRIPT
prevalence of PPD; therefore, this review has added further insights on PPD prevalence in
All geographical regions were represented in this review, with the highest coverage in
Asia (n=13) and North America (n=13), moderate coverage for Australia (n=7), Europe
(n=7), and the Middle East (n=10), and the lowest coverage for South America (n=5) and
PT
Africa (n=3). Studies conducted in Africa were mostly unable to meet our sample inclusion
RI
criteria of healthy mothers and infants; hence, the prevalence data for Africa are
underrepresented in this review. In addition, epidemiologic data were also the most lacking in
SC
low- and middle- income countries (i.e. South America and Africa). This could be due to a
poorly educated, non-English speaking population, and a society which does not prioritize
U
mental illnesses (Baxter et al., 2013). The lack of a representative global epidemiological data
AN
on mental illnesses can hinder the implementation of effective measures.
M
Our review also found statistical significant differences between geographical regions,
assessment tools used in each region were not accounted for and could be responsible such
TE
effects. Europe had the lowest prevalence of 8% (95% CI 0.05 - 0.11), while the Middle East
had the highest prevalence of 26% (95% CI 0.13 - 0.39); and the rest of Asia had a
EP
prevalence of 16% (95%CI 0.13 - 0.20). This falls between the reported range of prevalence
C
in Asia (including the Middle East) of 3.5% to 63.3% (Klainin and Arthur, 2009). Haque’s
AC
(2015) review also found that the Middle East had a higher prevalence of PPD compared to
other countries like the United States of America (12%), Sweden (13%), Australia (15%),
Canada (8%), and Norway (10%). These statistics correspond with Affonso and colleagues’
(2000) results from a cohort study, which showed that the prevalence of PPD and anxiety was
generally higher in Asia than Western countries. Differences in cultural practices may
contribute to this difference. In the Middle East and developing countries in Asia, girls are
13
ACCEPTED MANUSCRIPT
known to marry as young as 16 years old (Dixon, 1971), which has been shown to be a
significant predictor of PPD (O’Hara et al., 2007). Other key differences between Asian and
Western societies include religiosity (Hamdan and Tamim, 2011; Klainin and Arthur, 2009),
relationship with mother-in-law (Green et al., 2006; Haque et al., 2015), and practice of the
confinement period (Chang et al., 2014; Murray et al., 2015; Rahman et al., 2003).
PT
Westerners have more individualistic postpartum practices while Asian cultures are more
RI
reliant on others for social support during the postpartum period (Klainin and Arthur, 2009).
Therefore, the Asian practice of the confinement period, which involves special dietary
SC
preparations and infant care by the mother or mother-in-law, serves as a protective factor of
PPD (Chang et al., 2014; Murray et al., 2015). However, in the United Arab Emirates (UAE),
U
Muslims were found to have a higher risk of PPD than non-Muslims (Hamdan and Tamim,
AN
2011). Also, Middle Eastern women traditionally reside with their husband’s family after
M
marriage, this involves living with the mothers-in law who are usually highly involved in the
son’s and daughter-in-law’s life (Green et al., 2006). Hence, having a negative relationship
D
with one’s mother-in-law has been shown to lead to marital conflict, which in turn increases
TE
the risk of PPD (Green et al., 2006; Holroyd et al., 2011). Compared to a Western society
with a non-Muslim majority and an individualistic culture, these variances may be plausible
EP
reasons accounting for the difference in prevalence. In this review, most of the studies
C
(Astbury et al., 1994; Gotlib et al., 1989; Iwata et al., 2016; Leung et al., 2005) only
AC
investigated the sociodemographic risk factors of PPD and neglected cultural factors; this
suggests a need for more holistic future research on the predictors of PPD, including cultural
From our meta-analysis on the type of diagnostic tool used in each study, no
statistically significant differences were found. Our prevalence findings of 17% (95% CI 0.12
- 0.21) for clinical interviews and 18% (95% CI 0.15 - 0.20) for self-reported measures were
14
ACCEPTED MANUSCRIPT
largely similar as those reported in previous reviews (O’Hara et al., 2007; Woody et al.,
2017). Studies that adopted self-reported methods had varying time scales ranging from one
day to four years post childbirth, and varying score cut-offs ranging from 9 to 13. The
majority of the studies used different instruments to measure PPD, highlighting the
importance of the standardization of screening tools to provide a more accurate measure for
PT
PPD.
RI
In our meta-analysis, no significant difference was found between assessment time
points; however, an observable trend of increasing prevalence was noted from few days
SC
postpartum to more than 1 year postpartum. There were only a few studies (n=6) that
investigated prevalence after one year, compared to 24 studies that investigated prevalence in
U
the first 3 months postpartum. Previous published reports have suggested that the first three
AN
months postpartum is a high-risk timeframe for the onset of PPD (Cooper et al., 1988;
M
O’Hara et al., 1984). This could be the reason that many individual studies investigated the
prevalence of PPD and depressive symptoms only in the early postpartum period (first three
D
months) (Andrews-Fike, 1999; Cooper et al., 1988; Cox et al., 1993). However, there are a
TE
few longitudinal studies that reported persistence in depressive symptoms even after two
years (Chang et al., 2014; Small et al., 2003; Woolhouse et al., 2015). It was reported that
EP
women with no prior history of depression but who were depressed at eight months were
C
found to remain depressed even after their child turned two years old. In a study by Horowitz
AC
and Goodman (2004), women with elevated depressive symptoms between two to four weeks
postpartum remained depressed up to two years post childbirth. In Beeghly et al.’s study
(2003), depression scores peaked at two months postpartum, but there was no significant
change in depression scores at two months and three to 12 months postpartum. A review by
Goodman (2004) examining the course and incidence of PPD further reaffirmed the
persistence and high prevalence of depressive symptoms in the late postpartum period; the
15
ACCEPTED MANUSCRIPT
author also suggested possible differences in factors associated with persistent depressive
symptoms compared to depressive symptoms in the early postpartum period. This signifies
the importance of depression screening in the late postpartum period, extending beyond one
year post childbirth, and that appropriate follow-up treatment should be introduced.
In this review, the incidence of PPD was found to be 12% and it ranged from 3.4% to
PT
34% based on the six studies (Abbasi et al., 2014; Abdollahi et al., 2016; Gotlib et al., 1989;
RI
Lara et al., 2015; Sood and Sood, 2003; Stuart et al., 1998). Two studies reported incidence at
one month postpartum, three months postpartum, and six months postpartum respectively,
SC
with the peak incidence at three months (Abbasi et al., 2014). Congruent to this review, a
previous study (Stuart et al., 1998) found an incidence of 7.48% between 3 to 7 months
U
postpartum, which suggests a significant number of PPD onset during this period of time.
AN
However, as half of the included studies in this review were conducted in North America, the
M
results are not representative of global incidence and the small number of available studies
reduces the statistical power of the review and increases the margin of error. This is
D
supported by Baxter’s (2013) review on global epidemiology of mental health, which found
TE
that most incidence studies were done in Western Europe and North America, with almost
nonexistent incidence data available on other regions. This highlights the need for more
EP
incidence studies to be conducted globally, especially in the Middle East, Africa, and
C
developing countries in Asia, in order to identify the peak period for the new onset of PPD so
AC
The meta-regression analysis of 27 studies in this review did not show any population
was found to be similar across age, parity, and marital status. This is inconsistent with many
individual studies that reported demographic predictors such as age (Gotlib et al., 1989;
Green et al., 2006; Iwata et al., 2016; Katon et al., 2014), marital status (Beeghly et al., 2003;
16
ACCEPTED MANUSCRIPT
Faria Pereira et al., 2015; Hobfoll et al., 1995), parity (Faria Pereira et al., 2015; Green et al.,
2006; Iwata et al., 2016), and societal economic status (Beeghly et al., 2003; Campbell and
Cohn, 1991; Moraes et al., 2006) to be the predictors for PPD. Gavin’s (2009) findings stated
that primiparous mothers aged 36 years and above have a higher prevalence of PPD. A study
by Hobfall and colleagues (1995) found that single mothers and those without a cohabiting
PT
partner were at heightened risk for PPD compared to married and cohabiting mothers. The
RI
current review does not show any statistically significant differences among demographic
variables, probably due to the heterogeneity of the studies and the incomplete data presented
SC
in the included studies. Apart from sociodemographic predictors, studies have shown other
significant psychosocial predictors such as the availability of social support (Beck, 2001;
U
Leahy-Warren et al., 2012; Shorey et al., 2015), parenting self-efficacy(Leahy-Warren et al.,
AN
2012; Shorey et al., 2015), and self-esteem (Beck, 2001; Green et al., 2006; Tsao et al.,
M
2015). However, investigating the effects of these predictors on the prevalence of PPD was
beyond the scope of our review, which should be further examined in future reviews instead.
D
A major limitation of this review is that the included studies were published only in
TE
English and highly diversified, and had varying sampling methods that were adopted and
screening methods that were not standardized, which results in high heterogeneity between
EP
the studies. Also, the studies of non-representative populations were included in this review;
C
hence, this may not be reflective of the general population. Furthermore, the lack of available
AC
studies for certain subgroups (i.e. Africa) resulted in the analysis of a small study size, which
likely affected the overall results. Prevalence was found to be lower in Africa than Western
countries, but this was based on the analysis of only three studies; therefore, comparisons
may not be accurate. Lastly, due to the lack of significant findings from our meta-regression,
the results were unadjusted, and heterogeneity was not accounted for. However, the inclusion
of healthy mothers without prior history of psychiatric illnesses and who gave birth to healthy
17
ACCEPTED MANUSCRIPT
full-term infants provided greater insights about this specific group of neglected mothers. As
such, this review can be a stepping stone for future research in examining PPD and
This review has provided valuable insights on the incidence of depression among
PT
postpartum period and assess each mother for depression beyond one year irrespective of
RI
their psychiatry history. The review also highlights the importance of cultural relevance in
supporting mothers during this stressful transition period. Especially with the globalization of
SC
medical care, it is very important that healthcare professionals recognize the importance of
U
Future research should fill in the gaps highlighted in this review, including the limited
AN
data on PPD incidence, the under representation of Africa, and long-term PPD follow-ups
M
beyond one year postpartum. Future papers should also consider comparing both groups of
mothers (with versus without a history of depression) using the same analytical criteria such
D
that a more accurate comparison of observed prevalence will be available. Even though they
TE
are not examined in this review, other significant predictors, like social support (Shorey et al.,
2015) and household income (Beeghly et al., 2003), and risk factors such as living conditions,
EP
events during pregnancy, and birth complications, can be taken into account for sub-group
C
analysis in future reviews. Due to the inconsistent indicators of received social support across
AC
studies, as well as the difference in currency used to measure household income, we were
unable to include these variables in our review. As such, consistent definitions and
measurements of social support and household income as well as standard tools to measure
PPD should be considered when planning research globally so that future reviews can
CONCLUSION
The findings from this review presented the prevalence and incidence of PPD for a
specific group of healthy mothers without prior history of mental illnesses including PPD.
This group is often neglected in previous research; however, given that the PPD prevalence
PT
among this group of mothers is similar to those with a history of psychiatric illnesses, equal
RI
emphasis should be placed on them. Despite the lack of significant common predictors like
age, parity, and marital status on PPD prevalence, our review showed that Middle Eastern
SC
and Asian mothers have heightened risks of PPD, especially beyond six months postpartum.
Overall, this review sets the stage for future practice and research to focus on healthy mothers
U
during the postpartum period. This can potentially lead to the development of a more targeted
AN
treatment or an intervention method to prevent PPD in this specific group of mothers, and add
M
congruent care.
D
TE
Declaration of Interest
None
C EP
AC
19
ACCEPTED MANUSCRIPT
References
Abbasi, M., Van den Akker, O., Bewley, C., 2014. Persian couples' experiences of depressive
symptoms and health-related quality of life in the pre- and perinatal period. J.
Abdollahi, F., Agajani-Delavar, M., Zarghami, M., Lye, M.S., 2016. Postpartum mental
PT
health in first-time mothers: A cohort study. Iran. J. Psychiatry. Behav. Sci. 10(1).
Affonso, D.D., De, A.K., Horowitz, J.A., Mayberry, L.J., 2000. An international study
RI
exploring levels of postpartum depressive symptomatology. J. Psychosom. Res. 49(3),
SC
207-216.
Ali, N.S., Mahmud, S., Khan, A., Ali, B.S., 2013. Impact of postpartum anxiety and
U
depression on child’s mental development from two peri-urban communities of
AN
Karachi, Pakistan: a quasi-experimental study. BMC Psychiatry 13(1), 274.
Andrews-Fike, C., 1999. A review of postpartum depression. Prim. Care Companion J. Clin.
M
Astbury, J., Brown, S., Lumley, J., Small, R., 1994. Birth events, birth experiences and social
EP
Banti, S., Mauri, M., Oppo, A., Borri, C., Rambelli, C., Ramacciotti, D., Montagnani, M.S.,
C
Camilleri, V., Cortopassi, S., Rucci, P., Cassano, G.B., 2011. From the third month of
AC
depression. Results from the Perinatal Depression–Research & Screening Unit study.
Baxter, A.J., Patton, G., Scott, K.M., Degenhardt, L., Whiteford, H.A., 2013. Global
Epidemiology of Mental Disorders: What Are We Missing? PLoS ONE 8(6), e65514.
20
ACCEPTED MANUSCRIPT
Beck, C.T., 2001. Predictors of Postpartum Depression: An Update. Nurs. Res. 50(5), 275-
285.
Beeghly, M., Olson, K.L., Weinberg, M.K., Pierre, S.C., Downey, N., Tronick, E.Z., 2003.
Black mothers during the first 18 months postpartum. Matern. Child Health J. 7(3),
PT
157-168.
RI
Brummelte, S., Galea, L.A.M., 2016. Postpartum depression: Etiology, treatment and
SC
Campbell, S.B., Cohn, J.F., 1991. Prevalence and correlates of postpartum depression in first-
U
Chang, H.P., Chen, J.Y., Huang, Y.H., Tyan, J.Y., Yeh, C.J., Su, P.H., Chin-Hung Chen, V.,
AN
2014. Prevalence and factors associated with depressive symptoms in mothers with
M
Chee, C.Y.I., Lee, D.T.S., Chong, Y.S., Tan, L.K., Ng, T.P., Fones, C.S.L., 2005.
D
Cooper, P.J., Campbell, E.A., Day, A., Kennerley, H., Bond, A., 1988. Non-psychotic
EP
Cox, J.L., Murray, D., Chapman, G., 1993. A controlled study of the onset, duration and
Davey, S.J., Dziurawiec, S., O'Brien-Malone, A., 2006. Men's voices: Postnatal depression
from the perspective of male partners. Qual. Health Res. 16(2), 206-220.
Dixon, R.B., 1971. Explaining Cross-Cultural Variations in Age at Marriage and Proportions
Falah-Hassani, K., Shiri, R., Vigod, S., Dennis, C.L., 2015. Prevalence of postpartum
PT
Psychiatric Res. 70, 67-82.
RI
Faria Pereira, P., Carvalho, T.M., Ferreira Soares, G.C., Gualda, D.M.R., 2015. Screening of
SC
Braz. J. Nurs. 14(3), 1-10.
Ferrari, A.J., Charlson, F.J., Norman, R.E., Flaxman, A.D., Patten, S.B., Vos, T., Whiteford,
U
H.A., 2013. The Epidemiological Modelling of Major Depressive Disorder:
AN
Application for the Global Burden of Disease Study 2010. PLoS One 8(7), e69637.
M
Fisher, J., de Mello, M.C., Patel, V., Rahman, A., Tran, T., Holton, S., Holmesf, W., 2012.
90(2), 139-149.
Gavin, N.I., Gaynes, B.N., Lohr, K.N., Meltzer-Brody, S., Gartlehner, G., Swinson, T., 2005.
EP
Glavin, K., Smith, L., Sørum, R., 2009. Prevalence of postpartum depression in two
Goodman, J.H., 2004. Paternal postpartum depression, its relationship to maternal postpartum
depression, and implications for family health. J. Adv. Nurs. 45(1), 26-35.
Goodman, J.H., 2004. Postpartum depression beyond the early postpartum period. J. Obstet.
Green, K., Broome, H., Mirabella, J., 2006. Postnatal depression among mothers in the
United Arab Emirates: socio-cultural and physical factors. Psychol. Health Med.
PT
11(4), 425-431.
RI
Hahn-Holbrook, J., Cornwell-Hinrichs, T., Anaya, I., 2018. Economic and Health Predictors
SC
and Meta-Regression of 291 Studies from 56 Countries. Front. Psychiatry 8(248).
Hamdan, A., Tamim, H., 2011. Psychosocial risk and protective factors for postpartum
U
depression in the United Arab Emirates. Arch. Womens Ment. Health 4(2), 125-133.
AN
Han, B., Eskin, E., 2011. Random-Effects Model Aimed at Discovering Associations in
M
598.
D
Haque, A., Namavar, A., Breene, K.-A., 2015. Prevalence and Risk Factors of Postpartum
TE
Higgins, J.P.T., Thompson, S.G., Deeks, J.J., Altman, D.G., 2003. Measuring inconsistency
EP
Hobfoll, S.E., Ritter, C., Lavin, J., Hulsizer, M.R., Cameron, R.P., 1995. Depression
AC
Holroyd, E., Lopez, V., Chan, S.W.-C., 2011. Negotiating “doing the month”: an
Iwata, H., Mori, E., Sakajo, A., Aoki, K., Maehara, K., Tamakoshi, K., 2016. Prevalence of
PT
Jones, E., Coast, E., 2013. Social relationships and postpartum depression in South Asia: A
RI
systematic review. Int. J. Soc. Psychiatry 59(7), 690-700.
Katon, W., Russo, J., Gavin, A., 2014. Predictors of Postpartum Depression. J. Womens
SC
Health 23(9), 753-759.
Klainin, P., Arthur, D.G., 2009. Postpartum depression in Asian cultures: A literature review.
Leahy‐Warren, P., McCarthy, G., Corcoran, P., 2012. First‐time mothers: social support,
EP
maternal parental self‐efficacy and postnatal depression. J. Clin. Nurs. 21(3‐4), 388-
C
397.
AC
Letourneau, N.L., Dennis, C.-L., Benzies, K., Duffett-Leger, L., Stewart, M.,
Family Affair: Addressing the Impact on Mothers, Fathers, and Children. Issues
Liberati, A., Altman, D.G., Tetzlaff, J., Mulrow, C., Gøtzsche, P.C., Ioannidis, J.P.A., Clarke,
M., Devereaux, P.J., Kleijnen, J., Moher, D., 2009. The PRISMA statement for
PT
reporting systematic reviews and meta-analyses of studies that evaluate healthcare
RI
interventions: explanation and elaboration. Br. Med. J. 339(2009), b2700-b2700.
Monzon, C., di Scalea, T.L., Pearlstein, T., 2014. Postpartum psychosis: updates and clinical
SC
issues.(special report). Psychiatric Times 31(1), 26.
Moraes, I.G., Pinheiro, R.T., Silva, R.A., Horta, B.L., Sousa, P.L., Faria, A.D., 2006.
U
Prevalence of postpartum depression and associated factors. Rev. Saude Publica.
AN
40(1), 65-70.
M
Murray, L., Dunne, M.P., Van Vo, T., Anh, P.N., Khawaja, N.G., Cao, T.N., 2015. Postnatal
investigating prevalence and associations with social, cultural and infant factors.
TE
Murray, L., Fiori-Cowley, A., Hooper, R., Cooper, P., 1996. The Impact of Postnatal
EP
O’Hara, M.W., Neunaber, D.J., Zekoski, E.M., 1984. Prospective study of postpartum
158-171.
O’Hara, M.W., Schlechte, J.A., Lewis, D.A., Varner, M.W., 1991. Controlled Prospective
O’Hara, M.W., Swain, A.M., 1996. Rates and risk of postpartum depression-a meta-analysis.
Ozcan, N.K., Boyacioglu, N.E., Dinc, H., 2017. Postpartum Depression Prevalence and Risk
PT
Factors in Turkey: A Systematic Review and Meta-Analysis. Arch. Psychiatr. Nurs.
RI
31(4), 420-428.
Patel, M., Bailey, R.K., Jabeen, S., Ali, S., Barker, N.C., Osiezagha, K., 2012. Postpartum
SC
Depression: A Review. J. Health Care Poor Underserved2 3(2), 534-542.
Pearlstein, T., Howard, M., Salisbury, A., Zlotnick, C., 2009. Postpartum depression. Am. J.
2016, 4765310.
D
Rahman, A., Iqbal, Z., Harrington, R., 2003. Life events, social support and depression in
TE
Rasmussen, M.L.H., Strom, M., Wohlfahrt, J., Videbech, P., Melbye, M., 2017. Risk,
C
with no prior psychiatric history: A population-based cohort study. Plos Med. 14(9),
e1002392.
Shorey, S., Chan, S.W.-C., Chong, Y.S., He, H.-G., 2015. Predictors of Maternal Parental
Self-Efficacy Among Primiparas in the Early Postnatal Period. West. J. Nurs. Res.
37(12), 1604-1622.
26
ACCEPTED MANUSCRIPT
Small, R., Lumley, J., Yelland, J., 2003. Cross-cultural experiences of maternal depression:
associations and contributing factors for Vietnamese, Turkish and Filipino immigrant
Soe, N.N., Wen, D.J., Poh, J.S., Li, Y., Broekman, B.F.P., Chen, H., Chong, Y.S., Kwek, K.,
Saw, S.M., Gluckman, P.D., Meaney, M.J., Rifkin-Graboi, A., Qiu, A.Q., 2016. Pre-
PT
and Post-Natal Maternal Depressive Symptoms in Relation with Infant Frontal
RI
Function, Connectivity, and Behaviors. Plos One 11(4), e0152991.
Sood, M., Sood, A.K., 2003. Depression in pregnancy and postpartum period. Indian J.
SC
Psychiatry 45(1), 48-51.
Stein, A., Pearson, R.M., Goodman, S.H., Rapa, E., Rahman, A., McCallum, M., Howard,
U
L.M., Pariante, C.M., 2014. Effects of perinatal mental disorders on the fetus and
AN
child. Lancet 384(9956), 1800-1819.
M
Stuart, S., Couser, G., Schilder, K., O'Hara, M., Gorman, L., 1998. Postpartum anxiety and
186(7), 420-424.
TE
Tsao, Y., Creedy, D.K., Gamble, J., 2015. Prevalence and psychological correlates of
postnatal depression in rural Taiwanese women. Health Care Women Int 36(4), 457-
EP
474.
C
Upadhyay, R.P., Chowdhury, R., Salehi, A., Sarkar, K., Singh, S.K., Sinha, B., Pawar, A.,
AC
Vesga-López, O., Blanco, C., Keyes, K., Olfson, M., Grant, B.F., Hasin, D.S., 2008.
Psychiatric Disorders in Pregnant and Postpartum Women in the United States. Arch.
Villegas, L., McKay, K., Dennis, C.L., Ross, L.E., 2011. Postpartum Depression Among
PT
Rural Health 27(3), 278-288.
RI
Woody, C.A., Ferrari, A.J., Siskind, D.J., Whiteford, H.A., Harris, M.G., 2017. A systematic
SC
Affect. Disord. 219, 86-92.
Woolhouse, H., Gartland, D., Mensah, F., Brown, S.J., 2015. Maternal depression from early
U
pregnancy to 4 years postpartum in a prospective pregnancy cohort study:
AN
implications for primary health care. BJOG 122(3), 312-321.
M
D
TE
C EP
AC
ACCEPTED MANUSCRIPT
ACKNOWLEDGMENTS:
The authors would like to thank the National University Health System, Medical Publications
PT
RI
U SC
AN
M
D
TE
C EP
AC
ACCEPTED MANUSCRIPT
Figure Captions
Figure 1. PRISMA flowchart of the systematic review literature search illustrating the
identification of included studies.
Figure 2. Forest plot of 56 studies assessing the prevalence of postpartum depression among
mothers (n = 35,943). The size of the shaded square box indicates the weight of each study.
Horizontal lines show the 95% confidence intervals (CI). SE, standard error.
Figure 3. Forest plot assessing the prevalence of postpartum depression among mothers at
PT
different assessment time periods. The size of the shaded square box indicates the weight of
each study. Horizontal lines show the 95% confidence intervals (CI). SE, standard error.
Figure 4. Forest plot assessing the prevalence of postpartum depression among mothers in
RI
different geographical regions. The size of the shaded square box indicates the weight of each
study. Horizontal lines show the 95% confidence intervals (CI). SE, standard error.
SC
Figure 5. Forest plot assessing the prevalence of postpartum depression among mothers
according to method of assessment. The size of the shaded square box indicates the weight of
each study. Horizontal lines show the 95% confidence intervals (CI). SE, standard error.
U
Figure 6. Forest plot of six studies assessing the incidence of postpartum depression among
mothers (n = 1,351). The size of the shaded square box indicates the weight of each study.
AN
Horizontal lines show the 95% confidence intervals (CI). SE, standard error.
Figure 7. Funnel plot assessing the heterogeneity of the 56 studies on prevalence of
postpartum depression. Each plotted point represents the standard error (SE) and prevalence
M
for a single study. The vertical line represents average prevalence of 0.17 in the meta-analysis.
The slight asymmetry suggests possible publication bias.
D
TE
C EP
AC
ACCEPTED MANUSCRIPT
Table 1
Major characteristics of the studies for the prevalence and incidence of postnatal depression
PT
3rd month PP
Abdollahi et Middle East, Iran 838 3rd month PP EPDS (≥ 13)
al., 2016
RI
Prevalence Studies
Affonso et al., North America, 202 10 - 14 weeks SADS RDC
1990 USA pregnant;
SC
30 - 32 weeks
pregnant;
1 - 2 weeks PP;
4 weeks PP
U
Agoub et al., Africa, Morocco 144 2 weeks PP; MINI DSM-IV
2005 6 weeks PP;
AN
6 months PP;
9 months PP
Al Hinai et al., Middle East, 282 2 weeks PP; EPDS (≥ 13)
2014 Oman 8 weeks PP
M
12 months PP;
18 months PP
Bugdayci et al, Middle East, 1447 0 - 2 months EPDS (≥ 13)
C
7 - 12months
PP;
> 12 months PP
Campbell and North America, 1033 6-8 weeks PP SADS; RDC
Cohn, 1991 USA CES-D (≥
16)
Chang et al., Asia, Taiwan 111 6 - 24 months CES-D (≥
2014 PP; 25 - 48 16)
months PP
Chen, 1994 Asia, Taiwan 129 6 weeks PP BDI (≥ 10)
Chien et al., Asia, Taiwan 166 1month PP; CES-D (≥
2009 1 year PP 15)
ACCEPTED MANUSCRIPT
Cooper et al., Africa, South 98 2 months PP; SCID DSM-IV
2005 Africa 18 months PP
Corrêa, 2016 South America, 3060 1 - 3 months PP EPDS (≥ 11)
Brazil
Cox et al., Europe, England 232 6 months PP SPI; RDC
1993 EDPS (≥ 9)
Dennis et al., North America, 1125 1 week PP; EPDS (≥ 10)
2016 Canada 16 weeks PP
PT
Edhborg, 2010 Europe, Sweden 238 2 months PP; EPDS (≥ 12)
1 year PP
Faisal-Cury, South America, 113 10 days PP BDI (≥ 16)
2004 Brazil
RI
Faria, 2015 South America, 86 1 month PP; EPDS (≥ 12)
Brazil 2 months PP;
SC
4 months PP
Garcia-Esteve Europe, Spain 1123 6 weeks PP SCID-NP; DSM-IV
et al., 2003 EPDS (≥ 9)
U
Glasser et al., Middle East, Israel 104 < 3 months PP EPDS (≥ 13)
2011
AN
Glavin et al., Europe, Norway 2227 6 weeks PP EPDS (≥ 12)
2009
Gotlib et al., North America, 295 Mean 23.8 SADS; RDC
1989 Canada weeks pregnant; BDI (≥ 10)
M
mean 35.9
weeks pregnant;
mean 4.2 weeks
D
PP
Green et al., Middle East, UAE 56 3 months PP; EPDS (≥ 13)
TE
2006 6 months PP
Hamdan et al., Middle East, UAE 137 2nd trimester; MINI; DSM-IV
2010 3rd trimester; EPDS (≥ 10)
2 months PP
EP
Mathers, 2008
Husain et al., Middle East, 149 Mean 12 weeks EPDS (≥ 12)
2006 Pakistan PP
Iwata et al., Asia, Japan 2709 1, 2, 4, and 6 EPDS (≥ 9)
2016 months PP
Josefsson et Europe, Sweden 1558 1 - 5days PP; EPDS (≥ 10)
al., 2001 6 - 8 weeks PP;
6 months PP
Khalifa et al., Middle East, 236 3 months PP EPDS (≥ 12)
2015 Sudan
ACCEPTED MANUSCRIPT
Kitamura et al., Asia, Japan 111 1st trimester; SADS RDC
1994 3rd trimester;
1 day PP;
1 month PP
Lara et al., North America, 210 3rd trimester; SCID DSM-IV
2014 Mexico 6 weeks PP;
6 months PP
Leung et al., Asia, Hong Kong 269 6 weeks PP EPDS (≥ 13)
2005
PT
McMahon et Australia 100 4 months PP; CIDI DSM-IV
al., 2005 12 months PP
Moraes et al., South America, 410 30 - 45 days PP HAM-D (≥
RI
2006 Brazil 18)
Motzfeldt, Europe, Greenland 174 3 months PP EPDS (≥ 13)
2013
SC
Murray et al., Asia, Vietnam 431 1 - 6 months PP EPDS (≥ 13)
2015
O’Hara et al., North America, 4332 Mean 4.6 IDD DSM-IV
U
2007 USA months PP
Pawar et al., North America, 361 1 - 2 days PP PHQ-9 (≥
AN
2011 USA 10)
Rahaman and Middle East, 541 3rd trimester; SCAN ICD-10
Harrington, Pakistan 10 - 12weeks
M
2003 PP
Rahman and Middle East, 129 3rd trimester; SCAN ICD-10
Creed, 2007 Pakistan 3 months PP;
6 months PP;
D
12 months PP
Shafiei et al., Australia 39 4 months PP EPDS (≥ 13)
TE
2015
Small, R. et al., Australia 318 6 - 9 months PP EPDS (≥ 13)
2003
EP
Tannous et al., South America, 271 Mean 7.1 weeks EPDS (≥ 13)
2008 Brazil PP
Tsao et al., Asia, Taiwan 162 4th trimester; EPDS (≥ 13)
2015 6 weeks PP
PT
Yusuff et al., Asia, Malaysia 1362 1 months PP; EPDS (≥ 12)
2015 3 months PP;
6 months PP
RI
Zelkowitz et North America, 106 during EPDS (≥ 12)
al., 2008 Canada pregnancy;
2 months PP
SC
Note. BDI = Beck’s Depression Inventory; CES-D = Center for Epidemiologic Studies Depression
Scale; CIDI = Composite International Diagnostic Interview; CIS = Clinical Interview
Schedule; DASS-21 = Depression Anxiety Stress Scales; DSM-IV = Diagnostic and Statistical
Manual of Mental Disorders IV; EPDS = Edinburgh Postnatal Depression Scale; HAM-D = Hamilton
U
Depression Scale; ICD-10 = International Classification of Diseases, Tenth Revision; IDD =
Inventory to Diagnose Depression; MINI = Mini-International Neuropsychiatric Interview PHQ =
AN
Patient Health Questionnaire; PP = postpartum period; RDC = Research Diagnostic Criteria; SADS =
Social Avoidance and Distress Scale; SCAN = Schedules for Clinical Assessment in Neuropsychiatry;
SCID = Structured Clinical Interview for DSM-IV; SCID-NP = Structured Clinical Interview for
DSM-IV- Non Patient; SPI = Standardised Psychiatric Interview.
M
D
TE
C EP
AC
ACCEPTED MANUSCRIPT
Table 2
Results of the random effects meta-regression of demographic moderators for the prevalence
of postpartum depression among women with categorical moderators
Moderator Coefficient Standard Z-value p-value 95% CI
error
Age of mothers, mean -0.002 0.092 0.02 0.983 -0.17 – 0.18
Proportion of primiparous -0.013 0.008 -1.65 0.099 -0.27 – 0.00
mothers
Proportion of single -0.002 0.014 -0.13 0.899 -0.03 – 0.03
PT
mothers
Note. 95% CI = 95% confidence interval.
RI
U SC
AN
M
D
TE
C EP
AC
ACCEPTED MANUSCRIPT
Table 3
Results of the subgroup analyses of the prevalence of depression among postpartum women
with categorical moderators
Subgroup Comparison Studies, n Prevalence 95% CI
Assessment time period
0 - 3 months 24 0.14 0.11 - 0.17
4 - 6 months 18 0.16 0.13 - 0.19
7 - 12 months 7 0.20 0.11 - 0.29
More than 12 months 6 0.25 0.12 - 0.39
PT
Method of assessment
Clinical interviews 17 0.17 0.12 - 0.20
Self-report questionnaires 39 0.18 0.15 - 0.20
RI
Region
Asia 13 0.16 0.13 - 0.20
Africa 3 0.11 0.05 - 0.17
SC
Australia 5 0.19 0.18 - 0.21
Europe 6 0.08 0.05 - 0.11
Middle East 9 0.26 0.13 - 0.39
U
South America 5 0.19 0.18 - 0.21
North America 13 0.16 0.11 - 0.20
AN
Note. 95% CI = 95% confidence interval.
M
D
TE
C EP
AC
ACCEPTED MANUSCRIPT
Duplicates
PT
removed
(n = 3,569)
Records screened for title and abstract
(n = 12,387)
RI
Records removed
SC
due to inaccessible
Records screened for full-text and language full text (non-
(n = 325) response from the
original authors
U
when contacted)
or unavailable
AN
English text.
(n = 111)
Records screened for eligibility
(n = 214)
M
Records excluded
due to duplicated
D
studies, lack of
overall prevalence,
TE
irrelevant content
Studies eligible for inclusion
(i.e. antenatal,
(n = 58)
psychiatric
Studies Studies Studies disorders), invalid
EP
PT
RI
SC
U
AN
M
D
TE
EP
C
AC
ACCEPTED MANUSCRIPT
PT
RI
U SC
AN
M
D
TE
EP
C
AC
ACCEPTED MANUSCRIPT
PT
RI
U SC
AN
M
D
TE
EP
C
AC
ACCEPTED MANUSCRIPT
PT
RI
U SC
AN
M
D
TE
EP
C
AC
ACCEPTED MANUSCRIPT
PT
RI
U SC
AN
M
D
TE
EP
C
AC
ACCEPTED MANUSCRIPT
PT
RI
U SC
AN
M
D
TE
EP
C
AC
ACCEPTED MANUSCRIPT
Highlights
• Postpartum depression prevalence of 17% amongst healthy mothers
• Highest prevalence in Middle East and Asia compared to Western countries
• Increasing prevalence in time point assessments beyond three months
• No difference in prevalence through self-reports or clinical interviews
PT
RI
U SC
AN
M
D
TE
C EP
AC